However, this blockade of CXCR1/2 also enhances tumor infiltration, activation, and therapeutic efficacy of adoptively transferred murine NK cells [177], suggesting that cellular therapies can be improved by therapeutic modulation of the tumor environment. Here, CXCR1 is linked to neoplasm.